Finland· FI-REL-REL10572

Tilade Freoniton

A nedocromil product containing nedocromil sodium, registered in Finland by Sanofi Oy. The same ATC class is registered in 2 of our 19 countries.

ATC R03BC03

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedTilade FreonitonATCR03BC03REGISTER NO.FI-REL-REL10572PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Nedocromil is registered in 2 of 19 countries.

Countries holding a registration under ATC R03BC03 (nedocromil), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Nedocromil · ATC R03BC03

2 / 19 countries

  • Finlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Nedocromil sodium
Manufacturer
Sanofi Oy
Country
Finland (FI)
ATC code
R03BC03
ATC class
Nedocromil
Defined daily dose
8 mg, Inhal
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

5 interactions on record for nedocromil.

Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Nedocromil · interactions on record

5 records

  • 5 moderate

Most severe, free to view

  • Insulin (human)A10AB01moderate
  • Insulin (human)A10AC01moderate
  • Insulin (human)A10AD01moderate
  • Insulin (human)A10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Nedocromil in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All nedocromil products

Authorised across Europe · EMA

The same active substance is authorised in 1 EEA country. Names it is sold under:

  • Spain · Tilavist

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/41f12961-8362-4583-90a6-bc74d4752715
GET /v1/drugs/41f12961-8362-4583-90a6-bc74d4752715?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "8",
  "form": "inhalaatiosumute, suspensio",
  "route": null,
  "ddd_unit": "mg",
  "strength": "2 mg/annos",
  "atc_label": "nedokromiili",
  "ma_number": "13704",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL10572",
  "authorised_at": "1999-01-18"
}

See everything about nedocromil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.